PTPN2 and neoplasm: Low PTPN2 protein expression was associated with a higher risk for distant recurrence (Fig. 2a), this was even more apparent in the Luminal A subtype and tumours with HER2 overexpression, but not in the triple-negative subtype (Fig. 2b–d).